|
業績
|
| |
■論文
|
| |
【英文】
- Maki R, Horiuchi Y, Hayashi F, Nojiri S, Takehara I, Iwasaki Y, Miyake K, Miida T, Ai T, Tabe Y. Development of an evaluation model to determine disease severity in COVID-19 using basic laboratory markers. Int J Lab Hematol. 2022.
- Kimura K, Ai T, Horiuchi Y, Matsuzaki A, Nishibe
K, Marutani S, Saito K, Kaniyu K, Takehara I,
Uchihashi K, Ohsaka A, Tabe.Y. Automated
diagnostic support system with deep learning
algorithms for distinction of Philadelphia
chromosome-negative myeloproliferative neoplasms
using peripheral blood specimen. Sci
Rep.11:3367, 2021
- Hisasue M, Ai T, Kimura K, Matsuzaki A, Nishibe
K, Tabe.Y, Ohsaka A. Modification of the
Algorithm Used by Automated Hematology Analyzer
XN-3000 Improves Specificity in the Detection of
Schistocytes. Clin Lab. 67 :1. 2021
- Horiuchi Y, Hayashi F, Iwasaki Y, Matsuzaki A,
Nishibe K, Kaniyu K, Marutani S, Saito K,
Matsuoka S, Uchihashi K, Miida T, Ai T, Tabe Y.
Peripheral granular lymphocytopenia and
dysmorphic leukocytosis as simple prognostic
markers in COVID-19. Int J Lab Hematol. Online
ahead of print. 2021
- Saito K, Zhang Q, Yang H, Yamatani K, Ai T,
Ruvolo V, Baran N, Cai T, Ma H, Jacamo R,
Kuruvilla VM, Imoto J, Kinjo S, Ikeo K, Moriya
K, Suzuki K, Miida T, Kim YM, Vellano CP,
Andreeff M, Marszalek JR, Tabe Y, Konopleva MY.
Exogenous mitochondrial transfer and endogenous
mitochondrial fission facilitate AML resistance
to OxPhos inhibition. Blood Adv. Online ahead of
print. 2021.
- Tsuchiya.K, Hosaka.Y, Takahashi.T, Chonan.M,
Makita.Y, Katayama.T, Ai.T, Idei.M, Horiuchi.Y,
Yamatani.K, Wakita.M, Misawa.S, Okuzawa.A,
Miida.T, Naito.T, Takahashi,K, Tabe.Y. Meals and
room temperature storage do not significantly
affect feasibility of direct RT-PCR tests for
SARS-CoV-2 using saliva. Clin Lab 2021, in press
- Fukuda H, Seyama K, Ito K, Ai T, Nojiri S, Hori
S, Wakita M, Saito K, Shida Y, Nagura R,
Hasegawa M, Kanemoto C, Tokuhara M, Okajima K,
Yoshikawa Y, Katsuta N, Yamamoto T, Idei M,
Horiuchi Y, Yamatani K, Misawa S, Naito T, Miida
T, Sato H, Hattori N, Tabe.Y, Takahashi K.
SARS-CoV-2 seroprevalence in healthcare workers
at a frontline hospital in Tokyo. Sci
Rep.11:8380. 2021.
- Hiki M, Tabe.Y, Ai T, Matsue Y, Harada N,
Sugimoto K, Matsushita Y, Matsushita M, Wakita
M, Misawa S, Idei M, Miida T, Tamura N,
Takahashi K, Naito T. Seroprevalence of
anti-SARS-CoV-2 antibodies in Japanese COVID-19
patients. PLoS One.16 :e0249449.2021
-
Wakita M, Idei M, Saito K, Horiuchi Y, Yamatani
K, Ishikawa S, Yamamoto T, Igawa G, Hinata M,
Kadota K, Kurosawa T, Takahashi S, Saito T,
Misawa S, Akazawa C, Naito T, Miida T, Takahashi
K, Ai T, Tabe.Y. Comparison of the clinical
performance and usefulness of five SARS-CoV-2
antibody tests. PLoS One.16: e0246536. 2021
- Kimura K, Tabe Y, Ai T, Takehara I, Fukuda H,
Takahashi H, Naito T, Komatsu N, Uchihashi K,
Ohsaka A. A novel automated image analysis
system using deep convolutional neural networks
can assist to differentiate MDS and AA. Sci Rep.
9:13385. 2019
- Yamatani K, Tabe Y, Ai T, Kimura K, Takemura H,
Tsuchiya K, Yang H, Konishi A, Uchihashi K,
Horii T, Miida T, Ohsaka A. Performance
evaluation of the Sysmex DI-60 overview
application for tumor cell detection in body
fluid samples. Int J Lab Hematol. 41:e134-e138.
2019
- Kitamura H, Tabe Y, Ai T, Tsuchiya K, Yuri M,
Misawa S, Horii T, Kawaguchi A, Ohsaka A, Kimura
S. A new highly sensitive real-time
quantitative-PCR method for detection of
BCR-ABL1 to monitor minimal residual disease in
chronic myeloid leukemia after discontinuation
of imatinib. PLoS One. 14:e0207170. 2019
- Fujisawa S, Ueda Y, Usuki K, Kobayashi H, Kondo
E, Doki N, Nakao T, Kanda Y, Kosugi N, Kosugi H,
Kumagai T, Harada H, Shikami M, Maeda Y, Sakura
T, Inokuchi K, Saito A, Nawa Y, Ogasawara M,
Nishida J, Kondo T, Yoshida C, Kuroda H, Tabe Y,
Maeda Y, Imajo K, Kojima K, Morita S, Komukai S,
Kawaguchi A, Sakamoto J, Kimura S. Feasibility
of the imatinib stop study in the Japanese
clinical setting: delightedly overcome CML
expert stop TKI trial (DOMEST Trial). Int J Clin
Oncol. 24: 445-453. 2019
- Yokoyama N, Kim YJ, Hirabayashi Y, Tabe Y,
Takamori K, Ogawa H, Iwabuchi K. Kras promotes
myeloid differentiation through
Wnt/β-catenin signaling. FASEB Bioadv.
1:435-449. 2019
- Tabe Y, Saitoh K, Yang H, Sekihara K, Yamatani
K, Ruvolo V, Taka H, Kaga N, Kikkawa M, Arai H,
Miida T, Andreeff M, Spagnuolo PA, Konopleva M.
Inhibition of FAO in AML co-cultured with BM
adipocytes: mechanisms of survival and
chemosensitization to cytarabine. Sci Rep.
8:16837. 2018
- Tsuchiya K, Tabe Y, Ai T, Ohkawa T, Usui K, Yuri
M, Misawa S, Morishita S, Takaku T, Kakimoto A,
Yang H, Matsushita H, Hanami T, Yamanaka Y,
Okuzawa A, Horii T, Hayashizaki Y, Ohsaka A.
Eprobe mediated RT-qPCR for the detection of
leukemia-associated fusion genes. PLoS One.
13:e0202429,2018
- Takemura H, Ai T, Kimura K, Nagasaka K,
Takahashi T, Tsuchiya K, Yang H, Konishi A,
Uchihashi K, Horii T, Tabe Y, Ohsaka A.
Evaluation of cell count and classification
capabilities in body fluids using a fully
automated Sysmex XN equipped with high-sensitive
Analysis (hsA) mode and DI-60 hematology
analyzer system. PLoS One. 13:e0195923,2018
- Molina JR, Sun Y, Protopopova M, Gera S, Bandi
M, Bristow C, McAfoos T, Morlacchi P, Agip AA,
Al-Atrash A, Asara J, Bardenhagen J, Carrillo
CC, Carroll C, Chang E, Ciurea S, Cross JB,
Czako B, Deem A, Daver N, de Groot JF, Dong JW,
Feng N, Gao G, Gay J, Do MG, Greer J, Han J,
Henry VK, Hirst J, Huang S, Jiang Y, Kang Z,
Konoplev S, Liu G, Lodi A, Lofton T, Ma H, Matre
P, Mullinax P, Peoples M, Petrocchi A,
Rodriguez-Canale J, Serreli R, Shi T, Smith M,
Tabe Y, Theroff J, Tiziani S, Xu Q, Zhang Q,
Muller F, DePinho RA, Toniatti C, Heffernan TP,
Draetta GF, Konopleva M, Jones P, Di Francesco
ME, Marszalek JR. Oxidative phosphorylation
inhibitor exploits cancer vulnerability. Nat
Med.24:1036-1046. 2018
- Ai T, Tabe Y, Takemura H, Kimura K, Takahashi T,
Yang H, Tsuchiya K, Konishi A, Uchihashi K,
Horii T, Ohsaka A. Novel flowcytometry-based
approach of malignant cell detection in body
fluids using an automated hematology analyzer.
PLoS One. 13: e0190886, 2018.
- Tabe Y, Saitoh K, Yang H, Sekihara K, Yamatani
K, Ruvolo V, Taka H, Kaga N, Kikkawa M, Arai H,
Miida T, Andreeff M, Spagnuolo PA, Konopleva M.
Inhibition of FAO in AML cocultured with BM
adipocytes: mechanisms of survival and
chemosensitization to cytarabine. Scientific
Reports. 2018, in press
- Zhang Q, Shi C, Han L, Jain N, Roberts KG, Ma H,
Cai T, Cavazos A, Tabe Y, Jacamo RO, Mu H, Zhao
Y, Wang J, Wu SC, Cao F, Zeng Z, Zhou J, Mi Y,
Jabbour EJ, Levine R, Tasian SK, Mullighan CG,
Weinstock DM, Fruman DA, Konopleva M.Inhibition
of mTORC1/C2 signaling improves anti-leukemia
efficacy of JAK/STAT blockade in CRLF2
rearranged and/or JAK driven Philadelphia
chromosome-like acute B-cell lymphoblastic
leukemia. Oncotarget. 9: 8027-8041, 2018.
- Misawa K, Yasuda H, Araki M, Ochiai T, Morishita
S, Shirane S, Edahiro Y, Gotoh A, Ohsaka A,
Komatsu N. Mutational subtypes of JAK2 and CALR
correlate with different clinical features in
Japanese patients with myeloproliferative
neoplasms. Int J Hematol. in press, 2018
- Ochiai T, Yasuda H, Araki M, Misawa K, Morishita
S, Nudejima M, Hironaka Y, Shirane S, Edahiro Y,
Gotoh A, Ohsaka A, Komatsu N. The 2014 BCSH
criteria and the 2016 WHO criteria for essential
thrombocythemia: a comparison in a large-scale
cohort. Eur J Haematol. in press, 2018
- Watanabe N, Gotoh A, Shirane S, Hamano Y, Hirai
Y, Shimizu M, Nakamura A, Matsumoto K, Morita K,
Mori T, Ohsaka A, Komatsu N. Breakthrough
Exophiala dermatitidis infection during
prophylactic administration of micafungin during
second umbilical cord blood transplantation
after graft failure. Transpl Infect Dis. in
press, 2018
- Misawa K, Yasuda H, Araki M, Ochiai T, Morishita
S, Nudejima M, Hironaka Y, Shirane S, Edahiro Y,
Gotoh A, Ohsaka A, Komatsu N.
The 2016 WHO diagnostic criteria for
polycythemia vera renders an accurate diagnosis
to a broader range of patients including masked
polycythemia vera: Comparison with the 2008 WHO
diagnostic criteria. Am J Hematol. 92:E128-E130,
2017.
- Sekihara K, Saitoh K, Han L, Ciurea S, Yamamoto
S, Kikkawa M, Kazuno S, Taka H, Kaga N, Arai H,
Miida T, Andreeff M, Konopleva M,Tabe Y.
Targeting mantle cell lymphoma metabolism and
survival through simultaneous blockade of mTOR
and nuclear transporter exportin-1. Oncotarget.
8 : 34552-34564, 2017
- Tabe Y, Yamamoto S, Saitoh K, Sekihara K, Monma
N, Ikeo K, Mogushi K, Shikami M, Ruvolo VR,
Ishizawa J, Hail N, Kazuno S, Igarashi M,
Matsushita H, Yamanaka Y, Arai H, Nagaoka I,
Miida T, Hayashizaki Y, Konopleva M, Andreeff M.
Survival of acute monocytic leukemia cells is
driven by fatty acid oxidation-mediated
activation of AMPK in bone marrow adipocytes.
Cancer Res. 77:1453-1464. 2017
- Ai T, Yuri M, Tabe Y, Kakimoto A, Morishita S,
Tsuchiya K, Takamochi K, Kodama Y, Takahashi F,
Shigeki M, Horii T, Suzuki K, Takahashi K, Miida
T, Ohsaka A. Comparison of the Analytical
Performance Between cobas EGFR Assay and
PCR-Clamp Method in the Detection of EGFR
Mutations in Japanese Non-Small Cell Lung Cancer
Patients. Clin Lab. 63:1021-1026, 2017
- Watanabe N, Yasuda H, Morishita S, Aota Y,
Tomomatsu J, Tanaka M, Ohsaka A, Komatsu N.
Richter's syndrome with hypercalcemia induced by
tumor-associated production of parathyroid
hormone-related peptide. Case Rep Oncol 10:
123-126, 2017
- Sunami Y, Araki M, Kan S, Ito A, Hironaka Y,
Imai M, Morishita S, Ohsaka A, Komatsu N.
Histone acetyltransferase PCAF is required for
all-trans retinoic acid-induced granulocytic
differentiation in leukemia cells. J Biol Chem.
292: 2815-2829, 2017
- Horiuchi Y, TabeY, Kasuga K, Maenoh I, Idei M,
Horii T, Miida T, Ohsaka A. The efficacy of an
internet-based e-learning system using the
CellaVision Competency Software for continuing
professional development. Clin Chem Lab Med.
54:e127-31. 2016
- Yuri M, Tabe Y, Tsuchiya K, Sadatsuki R, Aoki J,
Horii T, Iba T, Ohsaka A. Evaluation of Factor
Xa-Specific Chromogenic Substrate Assays and the
Determination of Pharmacokinetics of
Fondaparinux. Clin Appl Thromb Hemost. 22:453-8.
2016
- Iba T, Emmi M, Hiki M, Nagayama M, Aihara K,
Tabe Y, Yuri M, Ohsaka A. Comparison of
prothrombin time tests used in the monitoring of
edoxaban and their evaluation as indicators of
the reversal effect. Int J Hematol.;103:665-72.
2016
- Araki M, Yang Y, Masubuchi N, Hironaka Y, Takei
H, Morishita S, Mizukami Y, Kan S, Shirane S,
Edahiro Y, Sunami Y, Ohsaka A, Komatsu N.
Activation of the thrombopoietin receptor by
mutant calreticulin in CALR-mutant
myeloproliferative neoplasms. Blood. 127:
1307-1316, 2016
- Kakimoto A, Otsubo K, Hanawa M, Kuwabara T,
Futaki-Sanbe T, Saito H, Ohsaka A. Acute
undifferentiated leukemia or minimally
differentiated acute myeloid leukemia: Further
emphasis on molecular analysis in leukemia
diagnosis. Juntendo Med J 62: 37-41, 2016
- Tabe Y, Yamamoto T, Maenou I, Nakai R, Idei M,
Horii T, Miida T, Ohsaka A. Performance
evaluation of the digital cell imaging analyzer
DI-60 integrated into the fully automated Sysmex
XN hematology analyzer system. Clin Chem Lab
Med. 53:281-9. 2015
|
| |
【和文】
- 田部陽子: AIを活用した血液形態診断. 検査と技術 Vol. 49 No. 12：1308-1310, 2021
- 田部 陽子．造血器腫瘍の治療標的としてのアミノ酸代謝経路. 血液内科 81：101-106,
2020
- 田部 陽子．血液細胞のAI分析システム. Medical Technology Vol.48,
No.7:708-709, 2020
- 横崎 典哉． 通山 薫, 稲葉 亨, 今福 裕司, 大久保 滋夫, 田部 陽子, 廣川 誠,
堀田 多恵子, 佐藤 雄一郎, 古川
泰司. 臨床検査医学研究を展開するために…知っておくべきこと、守るべきこと 2019年に実施した臨床検査を終了した検体の取扱いのアンケートについて．臨床病理
68：932-938, 2020
- 近藤 弘, 田部 陽子, 小池 由佳子, 池本 敏行, 常名 政弘, 鶴田 一人, 荒井 智子,
竹田 知広, 池田 尚隆, 岩崎 陽介, 小川 恵津子, 近藤 也寸紀, 中山 洋一, 永井
豊, 野村 尚之, 高野 邦彦, 米川 修, 直田 健太郎, 大庭 恵子, 落合 正好, 阿南
建一, 杉山 昌晃, 兜森 修, 東 克己, 川合 陽子, 通山 薫,
日本検査血液学会血球計数標準化小委員会.
標準化委員会報告-2018年度の提言 6社の基準自動血球分析装置による血球計数と白血球分類の2010、2013、2016年外部精度評価.
日本検査血液学会雑誌 20：132-142, 2019
- 山本 剛正, 田部 陽子, 石井 清, 三宅 一徳, 岩崎 陽介, 増田 亜希子, 松下 弘道,
堀井 隆, 佐藤 尚武, 大坂
顯通．炎症指標としての血算・血液像検査の利用状況(臨床医の意識調査結果)と桿状核好中球分類の有用性.
日本検査血液学会雑誌. 18:71-78.2017
- 堀内 裕紀, 田部 陽子, 佐藤 尚武, 三井田 孝. 血球形態診断のためのケースカンファレンス
貧血・血小板減少・肝脾腫が進行した乳児の1例. 日本検査血液学会雑誌. 18: 266-274.
2017
- 澤田 朝寛, 常名 政弘, 山本 剛正, 春日 加奈子, 藤巻 慎一, 三島 清司, 杉山
昌晃, 三宅 一徳, 田部 陽子, 三ツ橋 雄之, 土屋 達行,
WebPROワーキンググループ. Cella Vision Proficiency
Software(WebPRO)を用いた血液形態学検査e-ラーニングの試み.
日本検査血液学会雑誌18: 207-213. 2017
- 田部 陽子. 自動血球計数機を用いた体腔液検査. 臨床検査. 60:512-516.2016
- 石井 清, 田部 陽子, 佐野 麻衣, 岩崎 陽介, 清水 長子, 常名 正弘, 堀井 隆,
佐藤 尚武, 三井田 孝,大坂 顯通. 血液検査効率化に資する血液像目視再検基準の設定と評価
-自動血球分析装置XE-5000を用いた場合-. 日本検査血液学会雑誌.
16:20-27.2015
|
| |
■著書
|
| |
- Tabe Y, Konopleva M. Leukemia Stem Cells
Microenvironment. Adv Exp Med Biol.
2017;1041:19-32. doi:
10.1007/978-3-319-69194-7_3.
|
| |
■総説
|
| |
- Tabe Y, Konopleva M. Break the lifeline of AML
cells. Blood. 137:3465-3467.2021.
- Tabe Y, Konopleva M, Andreeff M. Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML. Front Oncol, 10:155,2020.
- Tabe Y, Konopleva M, Andreeff M. Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML. Front Oncol. 10:155.2020
- Tabe Y, Lorenzi PL, Konopleva M. Amino Acid Metabolism in Hematologic Malignancies and the Era of Targeted Therapy. 2019,134:1014-1023.
- Tabe Y, Tafuri A, Sekihara K, Yang H, Konopleva
M. Inhibition of mTOR kinase as a therapeutic
target for acute myeloid leukemia. Expert Opin
Ther Targets. 2017 ;21:705-714.
- Tabe Y, Konopleva M. Leukemia Stem Cells
Microenvironment. Adv Exp Med Biol.1041:19-32,
2017
|
| |
■学会発表
|
| |
【海外学会】
- Takehara I. A novel deep learning system for
diagnostic support of MPNs. Global Academic
Programs (GAP) Conference, Virtual Meeting ,
November 18 ,2020
- Kimura K, Ai T, Matsuzaki A, Nishibe K, Kaniyu
K, Marutani S, Takehara I, Uchihashi K, Ohsaka
A, Tabe Y. A novel multi-modal deep learning
diagnostic support system for MDS and MPN using
CBC related parameters and cell morphology y.
International Symposium on Technical Innovations
in Laboratory Hematology. Virtual Meeting, June
22-Sep 25, 2020
- Yamatani K, Ai T, Saitoh K, Yang H, Kinjo K,
Ikeo K, Ruvolo V, Mak PY, Harada H, Katayama K,
Sugimoto Y, Miida T, Konopleva M, Zhang W,
Carter BZ, Hayashizaki Y, Andreeff M. BCL2A1: a
novel target in refractory acute myeloid
leukemia with FLT3-ITD/D835 dual mutations. 62th
American Society of Hematology Annual Meeting,
Virtual Meeting, Dec.6, 2020
- Tabe Y, Saitoh K, Yamatani K, Yang H, Jacamo R,
Ma H, Ruvolo V, Zhang Q, Kuruvilla V, Baran N,
Imoto J, Ikeo K, Moriya K, Murakami-Tonami Y,
Suzuki K, Miida T, Andreeff M, Vellano CP,
Marszalek JR, Konopleva M. The direct
interactions with bone marrow microenvronment
confer resistance to the inhibition of Oxidative
Phosphorylation in AML. 62th American Society of
Hematology Annual Meeting, Virtual Meeting,
Dec.7, 2020
- Kimura K, Ai T, Matsuzaki A, Nishibe K, Kaniyu K, Marutani S, Takehara I, Uchihashi K, Ohsaka A, Tabe Y. A novel multi-modal deep learning diagnostic support system for MDS and MPN using CBC related parameters and cell morphology. International Symposium on Technical Innovations in Laboratory Hematology. Virtual Meeting, June 22-Sep 25, 2020 【AWARDEE】
- Kimura K, Tabe Y, Ai T, Matsuzaki A, Nishibe K,
Ebihara M, Kaniyu K, Takehara I, Uchihashi K,
Ohsaka A. A novel automated image analysis
system using deep convolutional neural networks
to diagnose MDS. 61th American Society of
Hematology Annual Meeting, Orlando, USA, Dec. 9,
2019
- Yang H, Tabe Y, Saitoh K, Yamatani K, Jacamo R,
Ma H, Ruvolo V, Zhang Q, Kuruvilla V, Baran N,
Imoto J, Ikeo K, Moriya K, Murakami-Tonami Y,
Suzuki K, Miida T, Andreeff M, Vellano CP,
Marszalek JR, Konopleva M. OxPhos inhibition
induces formation of tunneling nanotubes in AML
cells and facilitates mitochondrial transfer
from BM stroma to AML that contributes to
microenvironment-mediated drug-resistance of
AML. 61th American Society of Hematology Annual
Meeting, Orlando, USA, Dec 2019
- Yamatani K, Ai T, Saitoh K, Yang H, Suzuki K,
Hori A, Murakami-Tonami Y, Zhang W, Carter BZ,
Kinjo K, Ikeo K, Katayama K, Sugimoto Y, Harada
H, Miida T, Shah NP, Konopleva M, Hayashizaki Y,
Andreeff M, Tabe Y. CAGE transcriptome analysis
reveals BCL2A1 upregulation in FLT3-ITD/D835
dual mutated AML cells harboring complex
co-mutations. 61th American Society of
Hematology Annual Meeting, Orlando, USA, Dec. 7,
2019
- Zhang Q, Lodi A, Han L, Cai T, Kuruvilla VM,
Cavazos A, Ma H, Tabe Y, Marszalek JR, Tiziani
S, Konopleva S. Inhibiting mitochondria function
by Bcl-2 inhibitor venetoclax and complex I
inhibitor IACS-010759 eliminate leukemia cells
in pre-clinical AML models. 61th American
Society of Hematology Annual Meeting, Orlando,
USA, Dec. 9, 2019
- Yang H, Saitoh K, Imoto J, Ikeo K, Miida T, Tabe
Y. Cell adhesion to mesenchymal stem cells
mediates resistance to oxidative phosphorylation
inhibition in acute myeloid leukemia.
International Symposium on Technical Innovations
in Laboratory Hematology. Soul, Korea. July 10,
2019
- Kimura K, Tabe Y, Ai T, Takehara, Uchihashi K,
Ohsaka A. A novel automated image analysis using
deep convolutional neural networks in the
diagnosis of myelodysplastic syndromes. GAP 2019
Conference, Houston, USA, May 2019
- Tabe Y. Tunneling NanoTubes formation as a
mechanism of microenvironment-induced resistance
to OxPhos inhibition in AML. GAP 2019
Conference, Houston, USA, May 2019
- Tabe Y. Fatty acid metabolism and bone marrow
adipocytes in AML. ESH 3rd Scientific Workshop
on Haematological Tumour Microenvironment and
its Therapeutic Targeting, London, UK、Feb. 2019
- Hisasue M, Tabe Y, Kimura K, Ohsaka A.
Evaluation of fragmented red cells counting for
detection of schistocytes using Sysmex XN-2000.
International Symposium on Technical Innovations
in Laboratory Hematology. Vancouver, Vancouver,
Canada, May 2019
- Tsuchiya K, Kimura K, Yamamoto T, Nagasaka K,
Takemura H, Saito K, Misawa S, Horii T,
Uchihashi K, Tabe Y, Ohsaka A. Bone marrow
aspirate examination using the automated blood
cell analyzer Sysmex XN-2000R. International
Symposium on Technical Innovations in Laboratory
Hematology. Vancouver, Canada, May 2019
- Kimura K, Tabe Y, Homma M, Kurata H, Uchihashi
K, Ohsaka A. Deep Convolutional Neural Networks
for Morphologic Classification of hematopoietic
cells. International Symposium on Technical
Innovations in Laboratory Hematology, Brussels,
Belgium, May 2018
- Tabe Y, Tsuchiya K, Ohkawa T, Usui K, Yuri M,
Hanami T, Yang H, Yamanaka Y, Misawa S,
Hayashizaki Y, Ohsaka A. Rapid detection of
leukemia-related fusion transcripts by Eprobe
mediated RT-qPCR and melting curve analysis.
International Symposium on Technological
Innovations in Laboratory Hematology. Brussels,
Belgium, May 2018
- Tabe Y, Yang H, Sekihara K, Saitoh K, Ma H,
Ruvolo V, Imoto J, Ikeo K, Mogushi K, Hosoya M,
Hayashizaki Y, Yamanaka Y, Miida T, Andreeff M,
Marszalek JR, Konopleva M. Novel Oxidative
phosphorylation inhibitor IACS-010759 inhibits
p38MAPK-NFkB signaling pathways. GAP 2018
Conference, Stockholm, Sweden, May, 2018.
- Tabe Y, Takemura H, Kimura K, Konishi A, Ai T,
Uchihashi K, Horii T, Ohsaka A. Performance
evaluation of the Sysmex DI-60 overview
application for tumor cells detection in body
fluid. International Symposium on Technological
Innovations in Laboratory Hematology. Honolulu,
USA, May 2017
- Tabe Y. Transcriptional network supporting
survival of acute monocytic leukemia cells. MD
Anderson Cancer Center GAP Conference. Houston,
USA , May 2017
- Tabe Y, Takahashi T, Takemura H, Kimura K,
Konishi A, Horii T, Miida T, Ohsaka A. Novel
flowcytometry-based approach of tumor cells
detection in body fluid using Sysmex automated
hematology analyzer. International Symposium on
Technological Innovations in Laboratory
Hematology. Milano, Italy, May 2016
- Ohsaka A, Takahashi T, Takemura H, Kimura K,
Konishi A, Horii T, Miida T, Tabe Y. Novel
flowcytometry-based approach to detect tumor
cells in body fluid using Sysmex automated
hematology analyzer. AACC Annual Scientific
Meeting & Clinical Lab Expo. Philadelphia,USA,
July 2016
- Tabe Y, Ishii K, Kasuga K, Maenoh I, Horii T,
Miida T, Ohsaka A. Efficacy of the
internet-based e-leaning system using the
CellaVision Competency Software for continuing
professional development. International
Symposium on Technological Innovations in
Laboratory Hematology. Toronto, Canada, May 2013
- Takemura H, Tabe Y, Yamaguchi K, Ishii K, Kasuga
K, Horii T, Miida T, Ohsaka A. Detection of
tumor cells in body fluids by the automated
morphological analysis system CellaVision DM96
following the automated cell counting by the
Sysmex XE5000. American Association for Clinical
Chemistry Annual Meeting. Houston, USA. July
2013
- Tabe Y, Maenou I, Bengtsson HI, Ishii K, Miyake
K, Horiuchi Y, Idei M, Horii T, Satoh N, Miida
T, Ohsaka A: Performance evaluation of automated
morphological analysis of erythrocytes by
CellaVision DM96. International Symposium on
Technical Innovations in Laboratory Hematology,
Niece, France, May 2012
|
| |
【国内学会】
- 田部陽子: 骨髄異形成症候群の検査診断の最新情報 血球異形成判定の重要性／AIによる形態学的判定. 第28回日本輸血・細胞治療学会秋季シンポジウム, Web (10/8), 2021
- 田部陽子.
骨髄異形成症候群の検査診断の最新情報 血球異形成判定の重要性／AIによる形態学的判定.
日本輸血・細胞治療学会学術集会、Web、2021年10月
- 木村考伸、藍智彦、堀内裕紀、竹原一起、内橋欣也、田部陽子．AI/深層学習を応用した末梢血液形態の自動解析と骨髄異形成症候群および骨髄増殖性疾患の診断支援の試み．第67回日本臨床検査医学会学術集会,岩手オンデマンド、2020年11月
- 田部陽子.これからの血液学検査 AIを駆使した血液形態診断研究．日本医療検査科学会第52回大会,
横浜オンデマンド、2020年10月
- 木村考伸、松崎昭彦、西部久美子、蟹由公子、丸谷節子、竹原一起、藍智彦、内橋欣也2、大坂顯通、田部陽子.
AI/深層学習を応用した末梢血細胞画像解析と骨髄異形成症候群の自動鑑別に向けた試み. 第21回
日本検査血液学会学術集会、金沢オンデマンド、2020年7月【優秀演題賞 受賞演題】
- 土屋浩二, 木村考伸, 内橋欣也, 長坂佳織, 山本剛正, 竹村浩之, 三澤成毅, 田部陽子,
三井田孝, 大坂 顯通. 多項目自動血球分析装置XN-3000の骨髄検査への応用.
第66回日本臨床検査医学会学術集会, 岡山、2019年11月
- 土屋浩二、木村考伸、内橋欣也、長坂佳織、山本剛正、竹村浩之、三澤成毅、堀井隆、田部陽子、大坂顯通.
日本臨床検査医学会学術集会、東京、2018年11月
- 土屋 浩二、田部 陽子、竹村 浩之、木村
考伸、小西 綾、内橋 欣也、藍 智彦、堀井 隆、三澤 成毅、大坂 顯通.
血液像自動分析装置DI-60の体液分析アプリケーションを用いた体液中の悪性腫瘍細胞の検出.
日本検査血液学会学術集会、札幌、2017年7月
- 竹村 浩之, 田部 陽子, 高橋 敏宏, 木村 考伸, 小西 綾, 内橋 欣也, 長坂 佳織,
堀井 隆, 大坂 顯通.
多項目自動血球分析装置NXシリーズのスキャッタグラムパターン解析を用いた体液中の腫瘍細胞スクリーニングの試み.
日本検査血液学会学術集会、博多、2016年8月
- 田部 陽子．体腔液検査 細胞から病態まで 体腔液検査の現状と自動化への課題.
日本臨床検査医学会学術集会、神戸、2016年10月
- 田部 陽子. 血液検査の現場から 難題と、それを乗り切る創意工夫.
日本臨床検査自動化学会学術集会、横浜、2016年9月
|
| |
特許【出願中】
|
| |
|
|
|
|
|
|
各研究分野紹介一覧